RA Capital Nexus Fund II, Director: Dice Therapeutics DICE Buy · Filed 23/03/27

Trade details

Type: Insider buy
Amount: $4,136,223.63
Shares · price: 155,089 sh · $26.67 a share
Held after: 6,217,593 sh
Stock: Dice Therapeutics DICE
Person: RA Capital Nexus Fund IIDirector
Trade date: 23/03/23
Filed: 23/03/27
Days to filing: 4 days

5 insiders bought this week

Insiders buying this week: 5 insiders
Holding change: +2.6%

Dice Therapeutics trades, last 26 weeks

What else happened in Dice Therapeutics around then

Filed or reported within 30 days of the trade day · 23/02/21~23/04/22

RA Capital Nexus Fund II's recent trades

RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$45.7M
2,541,250 sh
$45.7M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.4M
133,750 sh
$2.4M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.1M
87,143 sh
$2.1M
Filed 05/06
Traded 05/05
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$1.3M
53,407 sh
$1.3M
Filed 05/06
Traded 05/06
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$347.3K
14,611 sh
$347.3K
Filed 05/06
Traded 05/06

RA Capital Nexus Fund II, Director — bought $4.1M of Dice Therapeutics DICE · 155,089 sh @ $26.67 | Whalegun